JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1999; 34:663-671
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kini, A.
Right arrow Articles by Sharma, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kini, A.
Right arrow Articles by Sharma, S. K.

Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course

Implications for early discharge after coronary intervention

Annapoorna Kini, MDa, Jonathan D. Marmur, MD, FACCa, Subhash Kini, MDa, George Dangas, MDa, Thomas P. Cocke, MD, FACCa, Sylvan Wallenstein, PhDa, Eppie Brown, RNa, John A. Ambrose, MD, FACCa and Samin K. Sharma, MD, FACCa

a Cardiac Catheterization Laboratory of the Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA



View larger version (25K):

[in a new window]
  		Figure 1 CK-MB elevation in relation to single- or multivessel intervention.

 


View larger version (8K):

[in a new window]
  		Figure 2 CK-MB elevation in relation to ACC/AHA lesion type.

 


View larger version (26K):

[in a new window]
  		Figure 3 CK-MB elevation in relation to diffuse or focal coronary disease.

 


View larger version (24K):

[in a new window]
  		Figure 4 CK-MB elevation in relation to interventional device type. *p = 0.01 for PTCA vs. non-balloon devices; **p = 0.07 for PRCA only vs. stent only.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.